Funded Grants

The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded. Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help those diagnosed with cancer.

2022
Maria Figueroa, MD
sPDZD2: A novel tumor suppressor in AML
Read More
2022
Patricia Jones, MD, MSCR
Targeted Navigation to Achieve Health Equity: Increasing Access to Care, Patient Engagement...
Read More
2022
Daniel Arango, Ph.D.
Investigating the mechanistic role of RNA Acetylation and Oxidation in Hepatocellular Carcinoma
Read More
2022
Dongyin Guan, PhD
Identification of causal targets for circadian medicine in liver cancer
Read More
2022
Theresa Guo, MD
Defining the relationship between aberrant splicing burden and anti-tumoral immunity in head...
Read More
2022
Sahar Nissim, M.D., Ph.D.
Developing an Interception Strategy for Pancreatic Cancer
Read More
2022
Kyle Payne, PhD
Elucidation of Tumor Cell-Intrinsic Mitochondrial Stress Signaling as a Novel Regulator of...
Read More
2022
Santosha Vardhana, MD, PhD
Regulation of T-cell exhaustion by environmental nutrient availability
Read More
2022
Priyanka Verma, Ph.D.
Replication driven vulnerabilities in Cyclin E overexpressing cancers
Read More
2022
Wenhan Zhu, Ph.D.
Bacterial toxin reshapes epithelial cell metabolism to promote carcinogenesis in the gut
Read More
2022
Neha Goel, MD
Social Genomic Alterations Associated with Neighborhood Disadvantage and Aggressive Breast Cancer Tumor...
Read More
2022
Arnaud Augert, Ph.D.
Dissecting the transcriptional and epigenetic mechanisms underlying small cell lung cancer initiation...
Read More
2022
Daniel Blanco-Melo, Ph.D.
Understanding the diverse roles of human endogenous retroviruses in cancer
Read More
2022
Priya Dedhia, MD, PhD
Intratumoral heterogeneity in adrenocortical carcinoma disease progression
Read More
2022
Rogelio Hernandez-Lopez, PhD
Engineering Next-generation Breast Cancer Cell Therapies: Targeting HER2 heterogeneity
Read More
2022
Keren Hilgendorf, PhD
Paracrine signaling networks in obesity-accelerated breast cancer
Read More